Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousPeripheral Blood Stem Cell TransplantationHodgkin DiseaseTransplantation ConditioningTreatment OutcomeStem CellsCombined Modality TherapyCyclophosphamideMultiple MyelomaMelphalanVincristineDisease-Free SurvivalDoxorubicinGraft vs Host DiseaseRemission InductionSalvage TherapyBone Marrow TransplantationPrednisoneSurvival RateHematologic NeoplasmsRecurrenceMyeloablative AgonistsSurvival AnalysisEtoposideLymphoma, Non-HodgkinLymphoma, Mantle-CellCytarabineLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell MobilizationAntibodies, MonoclonalLymphoma, FollicularHematopoietic Stem CellsPrognosisRetrospective StudiesLiver TransplantationCarmustineAntineoplastic AgentsGraft SurvivalWhole-Body IrradiationBusulfanThiotepaMesenchymal Stem Cell TransplantationBone Marrow PurgingTransplantation ChimeraFollow-Up StudiesTissue DonorsCord Blood Stem Cell TransplantationLymphoma, B-CellTime FactorsAntigens, CD34AmyloidosisChemotherapy, AdjuvantCell TransplantationKidney TransplantationDexamethasoneAntineoplastic Agents, AlkylatingBoronic AcidsEmbryonic Stem CellsPyrazinesAntigens, CD20Granulocyte Colony-Stimulating FactorLymphomaIfosfamideAdult Stem CellsCisplatinLeukemia, Myeloid, AcuteImmunosuppressive AgentsInduction ChemotherapyLeukapheresisHistocompatibility TestingThalidomideNeoplasm, ResidualAutograftsLymphoma, T-Cell, PeripheralMyelodysplastic SyndromesVidarabineHistocompatibilityNeoplasm Recurrence, LocalPodophyllotoxinCell DifferentiationLeukemiaMaintenance ChemotherapyGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsProspective StudiesAntibodies, Monoclonal, HumanizedNeoplasm StagingMesenchymal Stromal CellsNeoplasms, Second PrimaryTransplantation ImmunologyDrug Administration ScheduleMitoxantroneLung TransplantationNeural Stem Cells